Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas.

International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists - 1 Jan 1999

Zhai Y L, Kobayashi Y, Mori A, Orii A, Nikaido T, Konishi I, Fujii S

Abstract excerpt

The expression of estrogen receptor (ER), progesterone receptor (PR), tumor suppressor oncogene p53, and Ki-67 was compared in uterine smooth muscle tumors, including leiomyosarcoma (LMS), tumor of uncertain malignant potential (UMP), cellular leiomyoma (CL), bizarre leiomyoma (BL), and usual leiomyoma (UL). ER and PR were expressed in all ULs. PR was expressed in UL irrespective of the phase of the menstrual...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Immunohistochemistry

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Share to Reverse Transcriptase Polymerase Chain Reaction

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 9891238
DOI: 10.1097/00004347-199901000-00004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas.PMID 9891238Read ↗

p53 alterations in uterine leiomyosarcomas versus leiomyomas.Semantic proximity Read ↗

p53 immunoreactivity and mutation of the p53 gene in smooth muscle tumours of the uterine corpus.Semantic proximity Read ↗

Sex steroidal regulation of uterine leiomyoma growth and apoptosisSemantic proximity Read ↗

Advances in uterine leiomyoma research: the progesterone hypothesis.Semantic proximity Read ↗

Uterine Smooth Muscle TumorsSemantic proximity Read ↗

Relative quantitation of p53 and MDM2 gene expression in leiomyosarcoma; real-time semi-quantitative reverse transcription-polymerase chain reaction.Semantic proximity Read ↗

Up-Regulation by Progesterone of Proliferating Cell Nuclear Antigen and Epidermal Growth Factor Expression in Human Uterine LeiomyomaSemantic proximity Read ↗

Expression of exon 5 deleted estrogen receptor variant messenger RNA in human uterine myometrium and leiomyoma.Semantic proximity Read ↗

p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.Semantic proximity Read ↗

Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levels.Semantic proximity Read ↗

Prognostic significance of bcl-2 expression in leiomyosarcoma of the uterus.Semantic proximity Read ↗

Inhibition of estrogen-stimulated growth of uterine leiomyomas by selective estrogen receptor modulators.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.